Global Meningococcal Infections Vaccine Market Research Report 2022 - Market Size, Current Insights and Development Trends

Publisher Name :
Date: 06-Dec-2022
No. of pages: 125

The report focuses on the Meningococcal Infections Vaccine market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Meningococcal Infections Vaccine market.

Major Players in the Meningococcal Infections Vaccine market are:

Chongqing Zhifei Biological Products

Royal(Wuxi) Bio-Pharmaceutical

Zhejiang Tianyuan Bio-Pharmaceutical

Hualan Biological Engineering

Shanghai Institute of Biological Products

Wuhan Institute of Biological Products

Walvax Biotechnology

Sanofi-Pasteur

Beijing Tiantan Biological Products

Lanzhou Institute of Biological Products

On the basis of types, the Meningococcal Infections Vaccine market is primarily split into:

Meningococcal Conjugate Vaccines

Meningococcal Polysaccharide Vaccine

Serogroup B Meningococcal Vaccine

On the basis of applications, the market covers:

Children

Preteens/Teens

Adults

Major Regions or countries covered in this report:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Others

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029

Global Meningococcal Infections Vaccine Market Research Report 2022 - Market Size, Current Insights and Development Trends

Table of Content

1 Meningococcal Infections Vaccine Market Overview
1.1 Product Overview and Scope of Meningococcal Infections Vaccine Market
1.2 Meningococcal Infections Vaccine Market Segment by Type
1.2.1 Global Meningococcal Infections Vaccine Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Meningococcal Infections Vaccine Market Segment by Application
1.3.1 Meningococcal Infections Vaccine Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Meningococcal Infections Vaccine Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Meningococcal Infections Vaccine (2017-2029)
1.5.1 Global Meningococcal Infections Vaccine Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Meningococcal Infections Vaccine Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Meningococcal Infections Vaccine Industry
1.7 Impact of Carbon Neutrality on the Meningococcal Infections Vaccine Industry

2 Meningococcal Infections Vaccine Market Upstream and Downstream Analysis
2.1 Meningococcal Infections Vaccine Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Meningococcal Infections Vaccine Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream

3 Players Profiles
3.1 Chongqing Zhifei Biological Products
3.1.1 Chongqing Zhifei Biological Products Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Meningococcal Infections Vaccine Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Royal(Wuxi) Bio-Pharmaceutical
3.2.1 Royal(Wuxi) Bio-Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Meningococcal Infections Vaccine Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Zhejiang Tianyuan Bio-Pharmaceutical
3.3.1 Zhejiang Tianyuan Bio-Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Meningococcal Infections Vaccine Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Hualan Biological Engineering
3.4.1 Hualan Biological Engineering Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Meningococcal Infections Vaccine Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Shanghai Institute of Biological Products
3.5.1 Shanghai Institute of Biological Products Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Meningococcal Infections Vaccine Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Wuhan Institute of Biological Products
3.6.1 Wuhan Institute of Biological Products Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Meningococcal Infections Vaccine Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Walvax Biotechnology
3.7.1 Walvax Biotechnology Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Meningococcal Infections Vaccine Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Sanofi-Pasteur
3.8.1 Sanofi-Pasteur Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Meningococcal Infections Vaccine Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Beijing Tiantan Biological Products
3.9.1 Beijing Tiantan Biological Products Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Meningococcal Infections Vaccine Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Lanzhou Institute of Biological Products
3.10.1 Lanzhou Institute of Biological Products Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Meningococcal Infections Vaccine Market Performance (2017-2022)
3.10.4 Business Overview

4 Global Meningococcal Infections Vaccine Market Landscape by Player
4.1 Global Meningococcal Infections Vaccine Sales and Share by Player (2017-2022)
4.2 Global Meningococcal Infections Vaccine Revenue and Market Share by Player (2017-2022)
4.3 Global Meningococcal Infections Vaccine Average Price by Player (2017-2022)
4.4 Global Meningococcal Infections Vaccine Gross Margin by Player (2017-2022)
4.5 Meningococcal Infections Vaccine Market Competitive Situation and Trends
4.5.1 Meningococcal Infections Vaccine Market Concentration Rate
4.5.2 Meningococcal Infections Vaccine Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion

5 Global Meningococcal Infections Vaccine Sales, Revenue, Price Trend by Type
5.1 Global Meningococcal Infections Vaccine Sales and Market Share by Type (2017-2022)
5.2 Global Meningococcal Infections Vaccine Revenue and Market Share by Type (2017-2022)
5.3 Global Meningococcal Infections Vaccine Price by Type (2017-2022)
5.4 Global Meningococcal Infections Vaccine Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Meningococcal Infections Vaccine Sales, Revenue and Growth Rate of Meningococcal Conjugate Vaccines (2017-2022)
5.4.2 Global Meningococcal Infections Vaccine Sales, Revenue and Growth Rate of Meningococcal Polysaccharide Vaccine (2017-2022)
5.4.3 Global Meningococcal Infections Vaccine Sales, Revenue and Growth Rate of Serogroup B Meningococcal Vaccine (2017-2022)

6 Global Meningococcal Infections Vaccine Market Analysis by Application
6.1 Global Meningococcal Infections Vaccine Consumption and Market Share by Application (2017-2022)
6.2 Global Meningococcal Infections Vaccine Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Meningococcal Infections Vaccine Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Meningococcal Infections Vaccine Consumption and Growth Rate of Children (2017-2022)
6.3.2 Global Meningococcal Infections Vaccine Consumption and Growth Rate of Preteens/Teens (2017-2022)
6.3.3 Global Meningococcal Infections Vaccine Consumption and Growth Rate of Adults (2017-2022)

7 Global Meningococcal Infections Vaccine Sales and Revenue Region Wise (2017-2022)
7.1 Global Meningococcal Infections Vaccine Sales and Market Share, Region Wise (2017-2022)
7.2 Global Meningococcal Infections Vaccine Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)

8 Global Meningococcal Infections Vaccine Market Forecast (2022-2029)
8.1 Global Meningococcal Infections Vaccine Sales, Revenue Forecast (2022-2029)
8.1.1 Global Meningococcal Infections Vaccine Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Meningococcal Infections Vaccine Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Meningococcal Infections Vaccine Price and Trend Forecast (2022-2029)
8.2 Global Meningococcal Infections Vaccine Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Meningococcal Infections Vaccine Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Meningococcal Infections Vaccine Sales and Revenue Forecast (2022-2029)
8.2.3 China Meningococcal Infections Vaccine Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Meningococcal Infections Vaccine Sales and Revenue Forecast (2022-2029)
8.2.5 India Meningococcal Infections Vaccine Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Meningococcal Infections Vaccine Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Meningococcal Infections Vaccine Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Meningococcal Infections Vaccine Sales and Revenue Forecast (2022-2029)
8.3 Global Meningococcal Infections Vaccine Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Meningococcal Infections Vaccine Revenue and Growth Rate of Meningococcal Conjugate Vaccines (2022-2029)
8.3.2 Global Meningococcal Infections Vaccine Revenue and Growth Rate of Meningococcal Polysaccharide Vaccine (2022-2029)
8.3.3 Global Meningococcal Infections Vaccine Revenue and Growth Rate of Serogroup B Meningococcal Vaccine (2022-2029)
8.4 Global Meningococcal Infections Vaccine Consumption Forecast by Application (2022-2029)
8.4.1 Global Meningococcal Infections Vaccine Consumption Value and Growth Rate of Children (2022-2029)
8.4.2 Global Meningococcal Infections Vaccine Consumption Value and Growth Rate of Preteens/Teens (2022-2029)
8.4.3 Global Meningococcal Infections Vaccine Consumption Value and Growth Rate of Adults (2022-2029)
8.5 Meningococcal Infections Vaccine Market Forecast Under COVID-19

9 Industry Outlook
9.1 Meningococcal Infections Vaccine Market Drivers Analysis
9.2 Meningococcal Infections Vaccine Market Restraints and Challenges
9.3 Meningococcal Infections Vaccine Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Meningococcal Infections Vaccine Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Meningococcal Infections Vaccine Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Meningococcal Infections Vaccine Industry Development

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source
  • Global Cephalosporin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 109
    Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections. Cephalosporin originally derived from The fungus Acremonium, which was previously known as "Cephalosporium". The global Cephalosporin market was valued at US$ 1380.7 million in 2023 and is anticipated to reach US$ 1346.9 million by 2030, witnessing a CAGR of -0.3% during The forecast period 2024-2030. Market competition is intense. Qilu Antibiotics, Nectar Lifes......
  • Global Polymixin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Polymixin market size was valued at US$ 229.9 million in 2023. With growing demand in downstream market, the Polymixin is forecast to a readjusted size of US$ 291 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Polymixin market. Polymixin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Sepsis Partnering Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The Sepsis Partnering market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sepsis Partnering market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape......
  • Global Cephalosporin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156
    According to our LPI (LP Information) latest study, the global Cephalosporin market size was valued at US$ 1350.7 million in 2023. With growing demand in downstream market, the Cephalosporin is forecast to a readjusted size of US$ 1319.6 million by 2030 with a CAGR of -0.3% during review period. The research report highlights the growth potential of the global Cephalosporin market. Cephalosporin are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Amoxicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127
    According to our LPI (LP Information) latest study, the global Amoxicillin market size was valued at US$ 4512.7 million in 2023. With growing demand in downstream market, the Amoxicillin is forecast to a readjusted size of US$ 5711.7 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Amoxicillin market. Amoxicillin are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Metronidazole Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Metronidazole market size was valued at US$ 110.5 million in 2023. With growing demand in downstream market, the Metronidazole is forecast to a readjusted size of US$ 106.6 million by 2030 with a CAGR of -0.5% during review period. The research report highlights the growth potential of the global Metronidazole market. Metronidazole are expected to show stable growth in the future market. However, product differentiation, redu......
  • Global Drugs for Herpes Labialis (Oral Herpes) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Drugs for Herpes Labialis (Oral Herpes) market size was valued at US$ 2404.5 million in 2023. With growing demand in downstream market, the Drugs for Herpes Labialis (Oral Herpes) is forecast to a readjusted size of US$ 3402.2 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Drugs for Herpes Labialis (Oral Herpes) market. Drugs for Herpes Labialis (Ora......
  • Global Ampicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Ampicillin market size was valued at US$ 161.6 million in 2023. With growing demand in downstream market, the Ampicillin is forecast to a readjusted size of US$ 194.7 million by 2030 with a CAGR of 2.7% during review period. The research report highlights the growth potential of the global Ampicillin market. Ampicillin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......
  • Global Acinetobacter Infections Treatment Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Acinetobacter Infections Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Acinetobacter Infections Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Acinetobacter Infections Treatment market. Acinetobacter Infections Treatment are expected to show stable ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs